Medtronic shipped MiniMed Flex pumps that failed or skipped verification tests

Medtronic MiniMed is recalling the MiniMed Flex insulin pump (models MMT-8062 and MMT-8072) because some units were released with missing or failed verification test results in one or more of nine functional tests. Pumps that reached users without a passed check could have problems such as being inoperable at setup.

The company initiated the recall on August 20, 2026, and the FDA posted it on October 5, 2026 as a Class II action — a moderate risk where health problems are temporary or medically reversible and serious harm is unlikely.

No product-specific instructions accompanied the posting. FDA's standing advice for device recalls is that they do not always mean stopping use, and pump users should talk to their health care provider first.

FDA Class II recall (moderate risk) of MiniMed Flex pumps MMT-8062/MMT-8072, initiated August 20, 2026; some could be inoperable at setup

Pumps got to market without completed results from all nine functional verification tests, so the release gate did not hold them back.

An unverified pump can fail in ways testing exists to catch, including an inoperable device at setup.

The posting is Class II: even where harm stays temporary, devices were delivered without the verification records that would clear them for use.

A verification gate only means something if a failed or missing result stops shipment — otherwise quality control is paperwork, not protection.

The firm initiated the recall on August 20, 2026, and the FDA enforcement posting followed on October 5, 2026. Users were pointed to FDA's general recall advice rather than product-specific instructions, and the event remains listed as ongoing.